U2OS-CRISPR-SNAPf-Nup133 Cells
1 104,00 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Renseignements généraux
| Description | U2OS-CRISPR-SNAPf-Nup133 is a genetically engineered human osteosarcoma cell line derived from the parental U2OS background in which the endogenous NUP133 locus has been modified using CRISPR/Cas9-mediated genome editing to encode a C-terminal SNAPf tag. NUP133 is a core component of the Y-complex (NUP107-160 complex), a structural subcomplex essential for nuclear pore complex (NPC) assembly and maintenance. By introducing the SNAPf coding sequence in-frame at the endogenous locus, the fusion protein is expressed under native regulatory control, preserving physiological expression levels and subcellular localization. The SNAPf tag is a fast-labeling variant of the SNAP-tag, an engineered O6-alkylguanine-DNA alkyltransferase that covalently reacts with benzylguanine-conjugated substrates. This enables highly specific and versatile fluorescent labeling of Nup133 in live or fixed cells using cell-permeable or impermeable SNAP substrates. In U2OS-CRISPR-SNAPf-Nup133 cells, the fusion protein localizes to the nuclear envelope in a punctate pattern characteristic of nuclear pore complexes. Because tagging occurs at the endogenous locus, NPC stoichiometry and architecture are minimally perturbed, making this model suitable for quantitative super-resolution microscopy, single-molecule tracking, and kinetic analyses of NPC assembly and turnover. This cell line provides a robust platform for studying nuclear transport, nucleocytoplasmic trafficking dynamics, NPC biogenesis during interphase and post-mitotic nuclear reassembly, and structural organization of the Y-complex within the pore scaffold. The U2OS background offers flat morphology and large nuclei, facilitating high-resolution imaging. U2OS-CRISPR-SNAPf-Nup133 cells are particularly well suited for pulse-chase labeling experiments, correlative light and electron microscopy, and multicolor imaging approaches in combination with additional endogenously tagged nucleoporins or transport factors. |
|---|---|
| Organisme | Human |
| Tissu | Bone |
| Maladie | Osteosarcoma |
Caractéristiques
| Âge | 15 years |
|---|---|
| Genre | Female |
| Origine ethnique | Caucasian |
| Morphologie | Epithelial-like |
| Propriétés de croissance | Adherent |
Données réglementaires
| Référence | U2OS-CRISPR-SNAPf-Nup133 (Cytion catalog number 300666) |
|---|---|
| Niveau de biosécurité | 1 |
| NCBI_Numéro d'identification fiscale | 9606 |
| Déposant | The Ellenberg Lab (EMBL) |
| Statut OGM | GMO-S1: This human osteosarcoma cell line (U2OS-CRISPR-SNAPf-Nup133) contains a CRISPR-introduced SNAPf-Nup133 fusion, enabling fluorescent tagging of the Nup133 nucleoporin. The insert is stably present. This classification applies only within Germany and may differ elsewhere. |
Données biomoléculaires
| Expression des protéines | Nup133, SNAPf-tag |
|---|
Manipulation
| Milieu de culture | McCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a) |
|---|---|
| Suppléments | Supplement the medium with 10% FBS, 3.0 g/L Glucose, stable Glutamine, 2.0 mM Sodium pyruvate, 2.2 g/L NaHCO3, 1% NEAA |
| Réactif de dissociation | Accutase |
| Repiquage | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Contrôle de la qualité et analyse moléculaire
| Stérilité | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificat d'analyse (CoA)
| Numéro de lot | Type de certificat | Date | Numéro de catalogue |
|---|---|---|---|
| 300666-101225 | Certificat d'analyse | 22. Jan. 2026 | 300666 |
-
Related products
Related products
U2OS-CRISPR-SNAPf-Nup358/RanBP2 CellsOrganisme Human Tissu Bone Maladie Osteosarcoma 1 104,00 CAD$*